Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter ended June 30, 2025 and reviewed recent ...

Medtronic's decade-long underperformance stems from stagnant revenue growth, declining margins, and inconsistent returns on ...

Type 2 diabetes and obesity are interconnected health concerns, often creating a cycle of declining well-being. Addressing ...

Fasting may have potential health benefits for some people, including weight loss, heart health, blood sugar control, brain ...

The White House met with health tech business leaders on Wednesday to discuss advancements in health tech, including a public ...

Tandem Diabetes Care (TNDM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results ...

Maziar Mike Doustdar takes over at Novo Nordisk as the company reports weaker earnings than expected on generic challenges to ...

Emerging technology is becoming increasingly crucial to the efficiency and success of health systems. Forty-nine healthcare leaders spoke with Becker’s about the emerging technology that has surprised ...

Table of Contents The Simple Timing Trick That Changed Everything for Me The Nutrients That Don’t Play Nice Together What […] ...

An accompanying episode of the Annals of Family Medicine Podcast, featuring study authors Ann Sinéad Doherty, PhD, and Emma ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?